International Business Machines Corporation

New York Stock Exchange
Back to all articles
Bullish +65

International Business Machines (NYSE:IBM) Price Target Raised to $293. ...

📈 Morgan Stanley raised its price target to $293 with an equal weight rating following recent positive earnings performance.

🚀 Citigroup upgraded IBM to a 'buy' rating and increased its price target significantly from $285.00 to $375.00.

💰 The company reported quarterly revenue of $15.92 billion, representing a 9.5% increase compared to the prior year.

📊 IBM beat earnings estimates with $1.91 per share versus the consensus expectation of $1.81.

💵 The firm increased its quarterly dividend to $1.69 per share, resulting in an annualized yield of 3.1%.

🏦 Norges Bank established a new position worth approximately $2.45 billion in IBM shares during the fourth quarter.

📈 Capital World Investors raised its stake by 29.2%, now holding over 22 million shares valued at $6.52 billion.

🔼 Price T Rowe Associates increased its holdings by 83.4% to own 5.6 million shares worth $1.66 billion.

📉 HSBC downgraded the stock to 'reduce' and lowered its price target from $231.00 to $191.00.

🏛️ Weiss Ratings downgraded IBM from a 'buy' rating to a 'hold' rating in a recent research note.

📉 Corient Private Wealth boosted its stake by 359.6% to own nearly 1.9 million shares valued at $562 million.

📊 The consensus analyst rating for IBM is currently 'Moderate Buy' with an average price target of $301.83.

Bullish Signals
  • Morgan Stanley raised its price target to $293, indicating continued confidence in the company's valuation.
  • Citigroup upgraded the stock to a 'buy' rating and set a higher price target of $375.00.
  • IBM reported quarterly revenue of $15.92 billion, which exceeded analyst estimates of $15.60 billion.
  • The company achieved earnings per share of $1.91, surpassing the consensus estimate of $1.81 by $0.10.
  • Revenue grew 9.5% year-over-year, demonstrating solid top-line growth momentum.
  • IBM increased its quarterly dividend to $1.69 per share, raising the annualized yield to 3.1%.
  • Norges Bank acquired a new position worth $2.45 billion, signaling strong institutional interest.
  • Capital World Investors increased its stake by 29.2%, now holding over 22 million shares.
  • Price T Rowe Associates lifted its stake by 83.4% to own 5.6 million shares.
  • Corient Private Wealth boosted its position by 359.6% to own nearly 1.9 million shares.
  • Vanguard Group increased its holdings by 1.5%, adding over 1.4 million shares to its portfolio.
  • The company maintains a strong balance sheet with a net margin of 15.61% and a return on equity of 37.23%.
Risk Factors
  • HSBC downgraded IBM to a 'reduce' rating and lowered its price target from $231.00 to $191.00.
  • Weiss Ratings downgraded the stock from a 'buy' rating to a 'hold' rating, reflecting some caution.
Full Analysis
International Business Machines (IBM) received significant analyst attention this week, with Morgan Stanley raising its price target to $293 and Citigroup lifting theirs to $375 while upgrading the stock to a 'buy' rating. Conversely, HSBC downgraded IBM to 'reduce' with a lower target of $191, while Weiss Ratings cut its rating from 'buy' to 'hold'. Despite mixed individual opinions, the consensus remains a 'Moderate Buy' with an average price target of $301.83 based on ratings from fifteen buy-side analysts. IBM reported strong quarterly financial results for the period ending April 22nd, beating analyst expectations on both earnings and revenue. The company posted $1.91 in earnings per share compared to a consensus of $1.81, driven by revenue growth of 9.5% year-over-year to reach $15.92 billion. Key financial metrics included a net margin of 15.61%, a return on equity of 37.23%, and an annualized dividend yield of 3.1% following a quarterly payout increase. Institutional investors have been actively accumulating IBM shares during the fourth quarter, signaling confidence in the company's long-term trajectory. Major holders including Norges Bank, Capital World Investors, Price T Rowe Associates, Corient Private Wealth, and Vanguard Group all increased their positions significantly. Hedge funds and other institutional investors collectively own 58.96% of the outstanding stock, reflecting broad-based institutional support.